ALNY Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 1.50%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $34,733,444.48

Alnylam Pharmaceuticals Insider Trading History Chart

Alnylam Pharmaceuticals Share Price & Price History

^$273.15

▼ -1.31 (-0.48%)

As of 09/18/2024 01:00 AM ET

Days: 30 | 90 | 365

From Porter & Company | Ad

The AI boom is just getting started. And the real wealth has still to be made…

You must read this new presentation from Porter Stansberry.

Alnylam Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/20/2024	Yvonne Greenstreet	CEO	Sell	15,000	$280.00	$4,200,000.00	73,441
8/6/2024	Dennis A. Ausiello	Director	Sell	20,250	$262.00	$5,305,500.00	136
8/1/2024	Yvonne Greenstreet	CEO	Sell	15,148	$270.00	$4,089,960.00	73,441
7/11/2024	Yvonne Greenstreet	CEO	Sell	7,093	$261.00	$1,851,273.00	73,441
6/25/2024	Jeffrey V. Poulton	CFO	Sell	1,605	$231.00	$370,755.00	28,892
6/25/2024	Kevin Joseph Fitzgerald	EVP	Sell	1,198	$230.99	$276,726.02	14,181
6/25/2024	Pushkal Garg	CMO	Sell	2,103	$230.99	$485,771.97	15,609
6/25/2024	Yvonne Greenstreet	CEO	Sell	8,301	$230.99	$1,917,447.99	80,534
6/24/2024	David E. I. Pyott	Director	Sell	32,450	$220.69	$7,161,390.50	136
5/29/2024	Amy W. Schulman	Director	Sell	21,700	$148.60	$3,224,620.00	8,436
12/27/2023	Michael W. Bonney	Director	Sell	30,000	$195.00	$5,850,000.00	16,029
8/7/2023	Pushkal Garg	CMO	Sell	4,166	$183.89	$766,085.74	4,345
8/4/2023	Jeffrey V. Poulton	CFO	Sell	3,460	$185.85	$643,041.00	15,873
8/4/2023	Pushkal Garg	CMO	Sell	3,461	$185.85	$643,226.85	8,511
8/4/2023	Yvonne Greenstreet	CEO	Sell	4,057	$185.85	$753,993.45	35,216
4/27/2023	Akshay Vaishnaw	President	Sell	2,392	$194.59	$465,459.28	17,890
4/27/2023	Jeffrey V. Poulton	CFO	Sell	977	$194.59	$190,114.43	11,706
4/27/2023	Pushkal Garg	CMO	Sell	1,839	$194.59	$357,851.01	6,800
4/27/2023	Tolga Tanguler	EVP	Sell	1,476	$194.59	$287,214.84	1,801
4/27/2023	Yvonne Greenstreet	CEO	Sell	7,615	$194.59	$1,481,802.85	30,332
4/6/2023	Indrani Lall Franchini	EVP	Sell	3,500	$210.00	$735,000.00
3/3/2023	Pushkal Garg	CMO	Sell	18,072	$200.00	$3,614,400.00	4,345
2/2/2023	Indrani Lall Franchini	EVP	Sell	1,675	$226.01	$378,566.75	3,500
8/5/2022	Tolga Tanguler	EVP	Sell	1,841	$218.16	$401,632.56
8/3/2022	Tolga Tanguler	EVP	Sell	1,754	$210.00	$368,340.00	3,629
7/5/2022	Tolga Tanguler	EVP	Sell	1,754	$150.00	$263,100.00	1,754
4/1/2022	Steven M. Paul	Director	Sell	15,000	$170.69	$2,560,350.00	1,000
12/23/2021	Akshay Vaishnaw	Insider	Sell	2,879	$190.93	$549,687.47
11/12/2021	John Maraganore	CEO	Sell	33,978	$171.52	$5,827,906.56

⭕ [URGENT] Buy Alert just triggered

From Behind the Markets | Ad

My absolute favorite stock just hit a critical "buy now" trigger price.

Click here for the ticker >>>

SEC Filings (Institutional Ownership Changes) for Alnylam Pharmaceuticals (NASDAQ:ALNY)

92.97% of Alnylam Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Alnylam Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
9/5/2024	Sanctuary Advisors LLC	2,377	$0.58M	0.0%	N/A	0.002%
8/28/2024	Souders Financial Advisors	3,512	$0.85M	0.1%	+1.0%	0.003%
8/21/2024	Truist Financial Corp	1,728	$0.42M	0.0%	-26.5%	0.001%
8/16/2024	Regal Investment Advisors LLC	3,348	$0.81M	0.1%	+4.1%	0.003%
8/16/2024	Quarry LP	224	$54K	0.0%	-77.6%	0.000%
8/16/2024	Northwestern Mutual Wealth Management Co.	596	$0.15M	0.0%	+72.3%	0.000%
8/16/2024	Creative Planning	8,034	$1.95M	0.0%	+63.2%	0.006%
8/16/2024	Algert Global LLC	1,960	$0.48M	0.0%	N/A	0.002%
8/16/2024	Driehaus Capital Management LLC	32,489	$7.90M	0.1%	N/A	0.026%
8/15/2024	Susquehanna Fundamental Investments LLC	56,585	$13.75M	0.3%	-35.7%	0.045%
8/15/2024	Mackenzie Financial Corp	36,091	$8.77M	0.0%	+94.9%	0.029%
8/15/2024	The Manufacturers Life Insurance Company	329,037	$79.96M	0.1%	-2.4%	0.260%
8/15/2024	Millennium Management LLC	138,504	$33.66M	0.0%	-30.8%	0.109%
8/15/2024	MBB Public Markets I LLC	9,200	$2.24M	0.0%	N/A	0.007%
8/15/2024	Deerfield Management Company L.P. Series C	119,800	$29.11M	0.5%	N/A	0.095%
8/15/2024	APG Asset Management N.V.	93,565	$21.21M	0.0%	+38.8%	0.074%
8/15/2024	APG Asset Management US Inc.	33,807	$8.23M	0.0%	-5.9%	0.027%
8/15/2024	AQR Capital Management LLC	271,619	$65.86M	0.1%	+92.5%	0.215%
8/15/2024	Toronto Dominion Bank	12,151	$2.95M	0.0%	-6.4%	0.010%
8/14/2024	BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp	24,217	$5.89M	0.0%	+61.6%	0.019%
8/14/2024	Tri Locum Partners LP	45,000	$10.94M	2.8%	N/A	0.036%
8/14/2024	Xponance Inc.	21,076	$5.12M	0.1%	+7.0%	0.017%
8/14/2024	Avoro Capital Advisors LLC	400,000	$97.20M	1.3%	+33.3%	0.316%
8/14/2024	HighVista Strategies LLC	2,602	$0.63M	0.2%	N/A	0.002%
8/14/2024	Itau Unibanco Holding S.A.	327	$79K	0.0%	N/A	0.000%
8/14/2024	ProShare Advisors LLC	7,809	$1.90M	0.0%	-11.5%	0.006%
8/14/2024	Profund Advisors LLC	14,402	$3.50M	0.1%	+55.4%	0.011%
8/13/2024	Ensign Peak Advisors Inc	73,473	$17.85M	0.0%	-10.1%	0.058%
8/13/2024	Summit Trail Advisors LLC	929	$0.23M	0.0%	N/A	0.001%
8/13/2024	Skandinaviska Enskilda Banken AB publ	106,892	$25.97M	0.1%	+13.0%	0.085%
8/13/2024	Canada Pension Plan Investment Board	283,933	$69M	0.1%	+3.7%	0.224%
8/13/2024	Public Employees Retirement Association of Colorado	13,384	$3.25M	0.0%	-3.5%	0.011%
8/13/2024	Benjamin F. Edwards & Company Inc.	356	$87K	0.0%	-11.9%	0.000%
8/12/2024	Intech Investment Management LLC	7,145	$1.74M	0.0%	-34.4%	0.006%
8/12/2024	XTX Topco Ltd	1,480	$0.36M	0.0%	-69.2%	0.001%
8/12/2024	Hsbc Holdings PLC	54,155	$13.17M	0.0%	-26.9%	0.043%
8/12/2024	Elo Mutual Pension Insurance Co	11,372	$2.76M	0.1%	-0.8%	0.009%
8/12/2024	Vanguard Personalized Indexing Management LLC	7,153	$1.74M	0.0%	+17.5%	0.006%
8/12/2024	Amalgamated Bank	8,354	$2.03M	0.0%	+3.7%	0.007%
8/12/2024	Tredje AP fonden	19,483	$4.73M	0.0%	-1.6%	0.015%
8/12/2024	Meiji Yasuda Asset Management Co Ltd.	2,030	$0.49M	0.0%	+15.3%	0.002%
8/12/2024	E Fund Management Co. Ltd.	4,926	$1.20M	0.1%	+75.1%	0.004%
8/9/2024	Edgestream Partners L.P.	6,052	$1.47M	0.1%	-74.1%	0.005%
8/9/2024	Dimensional Fund Advisors LP	266,206	$64.70M	0.0%	+4.3%	0.210%
8/9/2024	Plato Investment Management Ltd	3,529	$0.86M	0.1%	-21.7%	0.003%
8/8/2024	Envestnet Asset Management Inc.	25,140	$6.11M	0.0%	-8.4%	0.020%
8/8/2024	Dai ichi Life Insurance Company Ltd	1,077	$0.26M	0.0%	N/A	0.001%
8/8/2024	SYM FINANCIAL Corp	892	$0.22M	0.0%	N/A	0.001%
8/8/2024	Federated Hermes Inc.	92,608	$22.50M	0.1%	-37.6%	0.073%
8/8/2024	DekaBank Deutsche Girozentrale	113,463	$27.89M	0.1%	+0.4%	0.090%
8/8/2024	Meeder Asset Management Inc.	321	$78K	0.0%	+1,237.5%	0.000%
8/8/2024	BOKF NA	5,751	$1.40M	0.0%	-14.3%	0.005%
8/8/2024	Forsta AP Fonden	25,200	$6.12M	0.1%	-63.1%	0.020%
8/8/2024	American Century Companies Inc.	1,354,169	$329.06M	0.2%	-1.4%	1.071%
8/8/2024	State of New Jersey Common Pension Fund D	48,458	$11.78M	0.1%	-33.9%	0.038%
8/7/2024	Daiwa Securities Group Inc.	11,292	$2.74M	0.0%	+3.4%	0.009%
8/7/2024	Andra AP fonden	3,100	$0.75M	0.0%	N/A	0.002%
8/7/2024	Royal London Asset Management Ltd.	282,345	$68.61M	0.2%	-13.6%	0.223%
8/7/2024	Ashton Thomas Private Wealth LLC	108	$26K	0.0%	N/A	0.000%
8/7/2024	HCR Wealth Advisors	924	$0.23M	0.0%	N/A	0.001%
8/6/2024	Prestige Wealth Management Group LLC	272	$66K	0.0%	-42.4%	0.000%
8/6/2024	Ballentine Partners LLC	1,389	$0.34M	0.0%	N/A	0.001%
8/6/2024	Emerald Advisers LLC	1,618	$0.39M	0.0%	-21.8%	0.001%
8/6/2024	Acadian Asset Management LLC	37,310	$9.06M	0.0%	+2,148.9%	0.029%
8/6/2024	EFG Asset Management Americas Corp.	16,992	$4.13M	0.8%	+56.1%	0.013%
8/6/2024	Los Angeles Capital Management LLC	1,188	$0.29M	0.0%	-59.9%	0.001%
8/6/2024	North Star Asset Management Inc.	1,310	$0.32M	0.0%	-13.2%	0.001%
8/5/2024	Arizona State Retirement System	34,736	$8.44M	0.1%	+0.6%	0.027%
8/5/2024	Victory Capital Management Inc.	38,680	$9.40M	0.0%	-1.8%	0.031%
8/5/2024	ANTIPODES PARTNERS Ltd	238,749	$59.43M	2.2%	+16.1%	0.189%
8/3/2024	National Bank of Canada FI	626	$0.15M	0.0%	-99.4%	0.000%
8/3/2024	TD Asset Management Inc	489,940	$119.06M	0.1%	+6.0%	0.387%
8/2/2024	JGP Global Gestao de Recursos Ltda.	1,233	$0.30M	0.4%	N/A	0.001%
8/1/2024	Rhumbline Advisers	173,327	$42.12M	0.0%	-0.2%	0.137%
8/1/2024	Gilbert & Cook Inc.	4,061	$0.99M	0.1%	-9.5%	0.003%
8/1/2024	CIBC Asset Management Inc	4,249	$1.03M	0.0%	+5.6%	0.003%
8/1/2024	GraniteShares Advisors LLC	3,870	$0.94M	0.3%	+21.8%	0.003%
8/1/2024	Privium Fund Management B.V.	19,393	$4.80M	1.3%	-7.2%	0.015%
7/31/2024	Van ECK Associates Corp	60,938	$14.81M	0.0%	+5.2%	0.048%
7/31/2024	Commonwealth Equity Services LLC	5,752	$1.40M	0.0%	+2.8%	0.005%
7/30/2024	Moloney Securities Asset Management LLC	907	$0.22M	0.0%	-62.0%	0.001%
7/30/2024	Sumitomo Mitsui DS Asset Management Company Ltd	12,114	$2.94M	0.0%	+27.6%	0.010%
7/30/2024	iA Global Asset Management Inc.	10,122	$2.46M	0.0%	+30.4%	0.008%
7/30/2024	Signaturefd LLC	1,383	$0.34M	0.0%	+25.8%	0.001%
7/29/2024	Crossmark Global Holdings Inc.	918	$0.22M	0.0%	N/A	0.001%
7/29/2024	Principal Financial Group Inc.	14,189	$3.45M	0.0%	-26.7%	0.011%
7/29/2024	Panagora Asset Management Inc.	19,810	$4.81M	0.0%	+165.7%	0.016%
7/29/2024	Tobam	29,731	$7.23M	1.1%	-57.0%	0.024%
7/29/2024	Burney Co.	25,439	$6.18M	0.2%	-6.0%	0.020%
7/26/2024	Breakwater Capital Group	1,025	$0.25M	0.1%	N/A	0.001%
7/26/2024	Allspring Global Investments Holdings LLC	259	$63K	0.0%	+54.2%	0.000%
7/26/2024	Liontrust Investment Partners LLP	5,083	$1.24M	0.0%	+3,288.7%	0.004%
7/26/2024	EFG Asset Management North America Corp.	18,584	$4.52M	0.8%	-6.8%	0.015%
7/25/2024	Baillie Gifford & Co.	6,032,656	$1.47B	1.1%	-8.9%	4.769%
7/24/2024	Everhart Financial Group Inc.	1,322	$0.32M	0.1%	N/A	0.001%
7/22/2024	Pallas Capital Advisors LLC	2,052	$0.49M	0.0%	N/A	0.002%
7/20/2024	China Universal Asset Management Co. Ltd.	26,509	$6.44M	0.9%	-26.0%	0.021%
7/19/2024	Chapin Davis Inc.	825	$0.20M	0.1%	N/A	0.001%
7/19/2024	Raymond James & Associates	16,257	$3.95M	0.0%	+7.2%	0.013%
7/19/2024	Values First Advisors Inc.	7,590	$1.84M	1.1%	-1.9%	0.006%

Data available starting January 2016

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. Its marketed products include ONPATTRO (patisiran) for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; AMVUTTRA for the treatment of hATTR amyloidosis with polyneuropathy in adults; GIVLAARI for the treatment of adults with acute hepatic porphyria; and OXLUMO for the treatment of primary hyperoxaluria type 1. In addition, the company develops patisiran for the treatment of transthyretin amyloidosis, or ATTR amyloidosis, with cardiomyopathy; cemdisiran to treat complement-mediated diseases; Belcesiran for the treatment of alpha-1 liver disease; Elebsiran to treat chronic HBV infection; Zilebesiran to treat hypertension; ALN-APP to treat Alzheimer's disease and cerebral amyloid angiopathy; and ALN-HSD to treat NASH. Further, it offers Fitusiran for the treatment of hemophilia, Inclisiran to treat hypercholesterolemia, lumasiran for the treatment of advanced PH1, and vutrisiran for the treatment of ATTR amyloidosis, which is in phase 3 clinical trial. Alnylam Pharmaceuticals, Inc. has strategic collaborations with Regeneron Pharmaceuticals, Inc. to discover, develop, and commercialize RNAi therapeutics for a range of diseases by addressing therapeutic targets expressed in the eye and CNS; and Roche to develop pharmaceutical products containing zilebesiran. It also has license and collaboration agreements with Novartis AG; Vir Biotechnology, Inc.; Dicerna Pharmaceuticals, Inc.; Ionis Pharmaceuticals, Inc.; and PeptiDream, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $273.15

$271.38

$277.59

50 Day Range

MA: $259.23

$233.81

$287.01

52 Week Range

Now: $273.15

$141.98

$287.55

Volume

655,918 shs

Average Volume

890,593 shs

Market Capitalization

$34.55 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.38

Who are the company insiders with the largest holdings of Alnylam Pharmaceuticals?: Alnylam Pharmaceuticals' top insider investors include:
Yvonne Greenstreet (CEO)
Jeffrey V Poulton (CFO)
Akshay Vaishnaw (President)
Michael W Bonney (Director)
Pushkal Garg (CMO)
Kevin Joseph Fitzgerald (EVP)
Amy W Schulman (Director)
Indrani Lall Franchini (EVP)
Tolga Tanguler (EVP)
David E I Pyott (Director)
Dennis A Ausiello (Director)
Learn More about top insider investors at Alnylam Pharmaceuticals.
Who are the major institutional investors of Alnylam Pharmaceuticals?: Alnylam Pharmaceuticals' top institutional shareholders include:
Baillie Gifford & Co. — 4.77%
American Century Companies Inc. — 1.07%
TD Asset Management Inc — 0.39%
Susquehanna International Group LLP — 0.00%
Avoro Capital Advisors LLC — 0.32%
The Manufacturers Life Insurance Company — 0.26%
Learn More about top institutional investors of Alnylam Pharmaceuticals stock.
Which major investors are selling Alnylam Pharmaceuticals stock?: In the last quarter, ALNY stock was sold by these institutional investors:
Baillie Gifford & Co.
National Bank of Canada FI
Millennium Management LLC
Federated Hermes Inc.
Royal London Asset Management Ltd.
Forsta AP Fonden
Tobam
D. E. Shaw & Co. Inc.
During the last year, company insiders that have sold Alnylam Pharmaceuticals company stock include:
Yvonne Greenstreet (CEO)
Jeffrey V Poulton (CFO)
Akshay Vaishnaw (President)
Michael W Bonney (Director)
Pushkal Garg (CMO)
Kevin Joseph Fitzgerald (EVP)
Amy W Schulman (Director)
Indrani Lall Franchini (EVP)
Learn More investors selling Alnylam Pharmaceuticals stock.
Which major investors are buying Alnylam Pharmaceuticals stock?: In the previous quarter, ALNY stock was acquired by institutional investors including:
AQR Capital Management LLC
Deerfield Management Company L.P. Series C
Avoro Capital Advisors LLC
Assenagon Asset Management S.A.
Tri Locum Partners LP
Acadian Asset Management LLC
ANTIPODES PARTNERS Ltd
Driehaus Capital Management LLC